Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study
暂无分享,去创建一个
Giovanni Rizzo | Pietro Cortelli | Claudia Testa | Caterina Tonon | Raffaele Lodi | Sabina Capellari | B. Barbiroli | D. Manners | G. Rizzo | R. Lodi | P. Cortelli | C. Testa | C. Tonon | E. Malucelli | B. Mostacci | P. Montagna | S. Capellari | Piero Parchi | R. Rinaldi | Piero Parchi | Barbara Mostacci | Giulia Pierangeli | Pasquale Montagna | R. Strammiello | G. Pierangeli | David Manners | Emil Malucelli | Bruno Barbiroli | Rosaria Strammiello | Rita Rinaldi
[1] M. Zeidler,et al. WHO manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob disease , 1998 .
[2] B. Steinhoff,et al. Diagnostic value of periodic complexes in Creutzfeldt–Jakob disease , 2004, Annals of neurology.
[3] I. Wilkinson,et al. Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt-Jakob disease. , 2003, Clinical radiology.
[4] S. Provencher. Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.
[5] M. Bahn,et al. Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease. , 1999, Archives of neurology.
[6] N. Venketasubramanian,et al. Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt-Jakob disease. , 2004, Magnetic resonance imaging.
[7] K. Hess,et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease , 2006, Neurology.
[8] K. Kallenberg,et al. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD. , 2006, Brain : a journal of neurology.
[9] P. Goldman-Rakic,et al. Proton magnetic resonance spectroscopy in Creutzfeldt‐Jakob disease , 1993, Neurology.
[10] Gavin Giovannoni,et al. Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. , 2004, Brain : a journal of neurology.
[11] D. Leibfritz,et al. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. , 1993, Developmental neuroscience.
[12] J. Collinge,et al. Neuroimaging findings in human prion disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.
[13] P Brown,et al. Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.
[14] R. Castellani,et al. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease , 2004, Neurology.
[15] H. Urbach,et al. Thalamic involvement in sporadic Creutzfeldt-Jakob disease: a diffusion-weighted MR imaging study. , 2003, AJNR. American journal of neuroradiology.
[16] A. Colchester,et al. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. , 2001, Clinical radiology.
[17] N. Ayache,et al. In vivo detection of thalamic gliosis: a pathoradiologic demonstration in familial fatal insomnia. , 2008, Archives of neurology.
[18] D. MacManus,et al. Short TE Quantitative Proton Magnetic Resonance Spectroscopy in Variant Creutzfeldt-Jakob Disease , 2006, European Radiology.
[19] J. Frahm,et al. In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy , 1991, The Lancet.
[20] D. MacManus,et al. Regional brain metabolite abnormalities in inherited prion disease and asymptomatic gene carriers demonstrated in vivo by quantitative proton magnetic resonance spectroscopy , 2006, Neuroradiology.
[21] C. Jack,et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. , 2008, Radiology.
[22] Pietro Cortelli,et al. Familial and sporadic fatal insomnia , 2003, The Lancet Neurology.
[23] Y. Itoyama,et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt–Jakob disease , 2004, Neurology.
[24] Horst Urbach,et al. MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease: a study on inter-observer agreement. , 2005, Brain : a journal of neurology.
[25] B. Miller,et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. , 2005, AJNR. American journal of neuroradiology.
[26] U. Heinemann,et al. Fatal familial insomnia: Clinical features and early identification , 2008, Annals of neurology.
[27] J. Laplanche,et al. CSF detection of the 14-3-3 protein in unselected patients with dementia. , 2002, Neurology.
[28] K. Kallenberg,et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. , 2006, AJNR. American journal of neuroradiology.
[29] J Mackenzie,et al. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. , 2006, Brain : a journal of neurology.
[30] H. Urbach,et al. Radiological assessment of Creutzfeldt-Jakob disease , 2007, European Radiology.
[31] H. Budka,et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt–Jakob disease , 2000, Neurology.
[32] Shu G. Chen,et al. Sporadic and familial CJD: classification and characterisation. , 2003, British medical bulletin.
[33] I. Zerr,et al. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. , 2000, Archives of neurology.
[34] Dhananjay Ghongade,et al. Neuroradiology , 2007, Indian Journal of Radiology and Imaging.
[35] B. Barbiroli,et al. Pathologic correlates of diffusion MRI changes in Creutzfeldt-Jakob disease , 2009, Neurology.
[36] Peter B Kingsley,et al. The imaging appearance of Creutzfeldt-Jakob disease caused by the E200K mutation. , 2006, Magnetic resonance imaging.
[37] H. Kretzschmar,et al. Molecular subtype-specific clinical diagnosis of prion diseases. , 2007, Veterinary microbiology.